Quarterly ResultJul 23, 2026, 04:08 PM
Medpace Q2 Revenue $707.3M, Net Income $121.4M; EPS $4.31
AI Summary
Medpace Holdings, Inc. reported strong financial results for the second quarter and first six months ended June 30, 2026. Revenue for Q2 increased to $707.3 million, with net income rising to $121.4 million and basic EPS at $4.31. For the six-month period, revenue reached $1.41 billion and net income was $245.2 million. The company also repurchased $294.7 million in common stock, but disclosed two class action lawsuits filed in the quarter.
Key Highlights
- Q2 2026 revenue increased to $707.3 million from $603.3 million in Q2 2025.
- Q2 2026 net income rose to $121.4 million from $90.3 million in Q2 2025.
- Q2 2026 basic EPS was $4.31, up from $3.16 in Q2 2025.
- Six months 2026 revenue reached $1.41 billion, up from $1.16 billion in 2025.
- Six months 2026 net income was $245.2 million, up from $204.9 million in 2025.
- Net cash provided by operating activities for six months 2026 was $313.8 million.
- Company repurchased 705,616 shares for $294.7 million during six months 2026.
- Two class action lawsuits were filed in Q2 2026 alleging misleading statements.
Price Impact
More from MEDP